elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties.
P2860
Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51316002-5482AD78-0477-443F-84CF-1F2C681FD809
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d63582560d2443b5c2dd6061d5548b75a334132
P2860
Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies